Nancy Harrison

Nancy Harrison Nancy Harrison is former Co-founder and President of MSI Methylation Sciences, a private venture backed development company with a novel treatment of depression in a Phase II clinical trial. She is a former Partner and Senior Vice President of Ventures West Management Inc. Nancy spent 13 years with Ventures West leading its life sciences practice in Canada and the U.S. She is one of the most experienced life sciences investors in the Canadian venture capital industry and was instrumental in Ventures West’s involvement in the sector and with companies such as Angiotech Pharmaceuticals Inc., AnorMed Inc., Salmedix Inc. and Oncogenix Pharmaceuticals Inc. During her time with Ventures West, the firm grew from approximately $80 million to over $750 million. Nancy has an undergraduate degree in Engineering from Queen’s University and an MBA from McGill University.